Asdis R. Thordardottir
Reykjavik, Iceland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 14, 2026
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study.
Journal: Blood cancer journal
Published: October 08, 2025
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance.
Journal: JAMA oncology
Published: May 29, 2025
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.
Journal: Annals of internal medicine
Published: May 20, 2024
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
Journal: Annals of internal medicine
Published: April 01, 2024
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study.
Journal: Blood cancer journal
Published: June 20, 2022
The first wave of COVID-19 and concurrent social restrictions were not associated with a negative impact on mental health and psychiatric well-being.
Journal: Journal of internal medicine
Published: February 03, 2022
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study.
Journal: Blood cancer journal
Published: September 03, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026